- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-14-0003813

About Calborn Lifescience Private Limited
Data last updated:
Calborn Lifescience Private Limited is a private limited company based in Kalol, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33110GJ2020PTC115786. Its GSTIN is 24AAICC9144N1Z8 (Gujarat).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.88 Cr. It is led by directors including Pareshkumar Jayantilal Patel and Nileshkumar Dhruvprasad Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No:3332 & 3333 Phase – 4 GIDC Estate Chhatral Ta:Kalol, Gujarat, India – 382729.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.45 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹10.82 Cr (net margin -243.2%) and EBITDA of -₹2.71 Cr (EBITDA margin -60.8%). Revenue has grown at a compounded annual rate (CAGR) of 147% over three years.
The company has about 38 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹38.41 Cr on record. Court records list 10 cases involving the company, including 10 filed against it.
Calborn Lifescience Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0003813). For more details, the company can be reached via its website calborn.in.
Company details
Recognitions & Rankings of Calborn Lifescience
Contact details
Calborn Lifescience Private Limited's registered office is in Kalol, Gujarat. Its website is calborn.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No:3332 & 3333 Phase – 4 GIDC Estate Chhatral Ta:Kalol, Gujarat, India – 382729
- IndustryPharma, API Manufacturers
To see the full contact details of Calborn Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Calborn Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Calborn Lifescience Private Limited, buy the company report.
Financials of Calborn Lifescience Private Limited
FY 2024 filings availableCalborn Lifescience Private Limited reported revenue of ₹4.45 Cr (up 238% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 147% over three years, including 238% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.71 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10.82 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -60.8% | ||||
| Net Profit Margin | -243.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Calborn Lifescience Private Limited, buy the company report.
Board of directors of Calborn Lifescience Private Limited
Calborn Lifescience has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samir Dilipkumar Shah | Additional Director | 03 Apr 2025 | 1 Years 6 Months | Current |
| Pareshkumar Jayantilal Patel | Director | 24 Sep 2022 | 4 Years 0 Months | Current |
| Nileshkumar Dhruvprasad Patel | Director | 24 Sep 2022 | 4 Years 0 Months | Current |
Peer comparison
Calborn Lifescience Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dasha Pharmaceuticals Private Limited | ₹4.54 Cr (FY 2025) | 25.0% | Hyderabad, Telangana, India | |||
| Moradiya Chemicals Private Limited | ₹4.52 Cr (FY 2025) | 36.0% | Mumbai, Maharashtra, India | |||
| Univive Healthcare Private Limited | ₹4.51 Cr (FY 2025) | 3.0% | Indore, M.P, Madhya Pradesh, India | |||
| Calborn Lifescience Private Limitedthis company | ₹4.45 Cr (FY 2025) | -₹10.82 Cr | -243.2% | 238.0% | 38 | Kalol, Gujarat, India |
| Cohesion Biotec Private Limited | ₹4.03 Cr (FY 2024) | -31.0% | Ghumasan, Gujarat, India |
To see the full peer comparison of Calborn Lifescience Private Limited, buy the company report.
Auditor
Calborn Lifescience Private Limited is audited by PARTH BHARATKUMAR MEHTA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARTH BHARATKUMAR MEHTA | FY 2024 | 169455 |
Shareholding
The shareholding of Calborn Lifescience Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Calborn Lifescience Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Feb 2022 | 100541368 | Others | ₹38.41 Cr | Open |
To see the full charge records of Calborn Lifescience Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Calborn Lifescience Private Limited has 10 court cases on record: 10 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 0 |
Cases on record (4 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mahesana, Gujarat | Court case (CR EN) | Filed against the company by The Meh. Arbu. Co.Op. Bank Li. Meh. Na Adhi. Shri. Anilkumar Jayantibhai Patel | Disposed |
| District court, Mahesana, Gujarat | Criminal complaint | Filed against the company by The Meh. Arbu. Co.Op. Bank Li. Meh. Na Adhi. Shri. Anilkumar Jayantibhai Patel | Disposed |
| District court, Mahesana, Gujarat | Court case (CR EN) | Filed against the company by The Meh. Arbu. Co.Op. Bank Li. Meh. Na Adhi. Shri. Anilkumar Jayantibhai Patel | Disposed |
| District court, Mahesana, Gujarat | Criminal complaint | Filed against the company by The Meh. Arbu. Co.Op. Bank Li. Meh. Na Adhi. Shri. Anilkumar Jayantibhai Patel | Disposed |
To see the full case history of Calborn Lifescience Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Calborn Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Calborn Lifescience Private Limited has a workforce of 38 employees on its EPFO records as of Feb 24, 2025, across 1 active EPFO establishment.
GST
Calborn Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICC9144N1Z8 | Gujarat | Active | 03 Sep 2020 |
To see the full GST registrations and return filing status of Calborn Lifescience Private Limited, buy the company report.
Recent activity
Calborn Lifescience Private Limited has 6 board changes on record since 2020: 3 appointments and 3 cessations. The latest: Samir Dilipkumar Shah was appointed as Additional Director on 03 Apr 2025.
Frequently asked questions
Calborn Lifescience is an active private limited company based in Kalol, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 24 August 2020 (6+ years old) and is registered under CIN U33110GJ2020PTC115786.
Calborn Lifescience has 3 current directors:
- Samir Dilipkumar Shah - Additional Director
- Pareshkumar Jayantilal Patel - Director
- Nileshkumar Dhruvprasad Patel - Director
The latest financial statements of Calborn Lifescience on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Calborn Lifescience is 24AAICC9144N1Z8, registered in Gujarat.
The CIN (Corporate Identification Number) of Calborn Lifescience is U33110GJ2020PTC115786. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Calborn Lifescience has 10 court cases on record: 10 filed against it.
Calborn Lifescience was incorporated on 24 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Calborn Lifescience by revenue are Dasha Pharmaceuticals Private Limited, Moradiya Chemicals Private Limited, Univive Healthcare Private Limited, Cohesion Biotec Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Samir Dilipkumar Shah was appointed as Additional Director on 03 Apr 2025. Mittalkumar Jagdishbhai Patel ceased to be Director on 24 Sep 2022. Nileshkumar Dhruvprasad Patel was appointed as Director on 24 Sep 2022. Calborn Lifescience has 6 board changes on record in total.
Yes, Calborn Lifescience is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-14-0003813).
Calborn Lifescience can be reached through the website calborn.in. Its registered office is in Kalol, Gujarat, India.